candesartan/hydrochlorothiazide 8mg/12.5mg tablets
aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - candesartan cilexetil, hydrochlorothiazide - tablet - candesartan cilexetil 8 mg hydrochlorothiazide 12.5 mg - agents acting on the renin-angiotensin system
candesartan/hydrochlorothiazide 16mg/12.5mg tablets
aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - candesartan cilexetil, hydrochlorothiazide - tablet - candesartan cilexetil 16 mg hydrochlorothiazide 12.5 mg - agents acting on the renin-angiotensin system
candesartan/hydrochlorothiazide 32mg/12.5mg tablets
aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - candesartan cilexetil, hydrochlorothiazide - tablet - candesartan cilexetil 32 mg hydrochlorothiazide 12.5 mg - agents acting on the renin-angiotensin system
candesartan/hydrochlorothiazide 32mg/25mg tablets
aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - candesartan cilexetil, hydrochlorothiazide - tablet - candesartan cilexetil 32 mg hydrochlorothiazide 25 mg - agents acting on the renin-angiotensin system
avsartan hct 300/12.5 irbesartan 300 mg and hydrochlorothiazide 12.5 mg tablets blister pack
arrotex pharmaceuticals pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 300 mg - tablet, film coated - excipient ingredients: povidone; polysorbate 80; sodium starch glycollate type b; hypromellose; colloidal anhydrous silica; magnesium stearate; mannitol; iron oxide red; iron oxide yellow; titanium dioxide; carnauba wax; macrogol 3350 - indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.
avsartan hct 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablets blister pack
arrotex pharmaceuticals pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 150 mg - tablet, film coated - excipient ingredients: povidone; hypromellose; colloidal anhydrous silica; mannitol; polysorbate 80; sodium starch glycollate type b; magnesium stearate; titanium dioxide; iron oxide yellow; iron oxide red; carnauba wax; macrogol 3350 - indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.
telmisartan/hydrochlorothiazide 80mg/12.5mg tablets
accord healthcare limited - hydrochlorothiazide; telmisartan - tablet - 80 mg/12.5 milligram(s) - angiotensin ii antagonists and diuretics; telmisartan and diuretics
telmisartan/hydrochlorothiazide 80mg/25mg tablets
accord healthcare limited - hydrochlorothiazide; telmisartan - tablet - 80 mg/25 milligram(s) - angiotensin ii antagonists and diuretics; telmisartan and diuretics
exforge hct 10/320/25 amlodipine/valsartan/hydrochlorothiazide tablet blister pack
novartis pharmaceuticals australia pty ltd - hydrochlorothiazide, quantity: 25 mg; valsartan, quantity: 320 mg; amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg) - tablet, film coated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; crospovidone; hypromellose; purified talc; iron oxide yellow; macrogol 4000 - exforge hct is indicated only as substitution therapy for the treatment of hypertension in patients whose blood pressure is already adequately controlled on the triple combination of amlodipine, valsartan and hydrochlorothiazide taken either as three single component formulations or as dual-component formulation with a single component formulation, all components at the same dose level. treatment should not be initiated with these fixed-dose combinations (see dosage and administration).
exforge hct 10/160/25 amlodipine/valsartan/hydrochlorothiazide tablet blister pack
novartis pharmaceuticals australia pty ltd - hydrochlorothiazide, quantity: 25 mg; amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); valsartan, quantity: 160 mg - tablet, film coated - excipient ingredients: crospovidone; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; hypromellose; purified talc; iron oxide yellow; macrogol 4000 - exforge hct is indicated only as substitution therapy for the treatment of hypertension in patients whose blood pressure is already adequately controlled on the triple combination of amlodipine, valsartan and hydrochlorothiazide taken either as three single component formulations or as dual-component formulation with a single component formulation, all components at the same dose level. treatment should not be initiated with these fixed-dose combinations (see dosage and administration).